Recent Company News

• 07:03 AM ET Aug 25, 2026
  

  BioCryst announces approval of ORLADEYO for pediatric HAE patients in Japan aged 2 to <12 years ($9.68, 0.00)

• 03:08 AM ET Aug 07, 2026
  

  Paltac to be delisted on 10-Aug (¥6630.0000, 0)

• 02:35 AM ET Aug 05, 2026
  

  Medipal Holdings reports Q1 net income attributable ¥13.65B vs FactSet ¥9.92B [1 est] (¥2713.5000, 0)

• 10:51 PM ET Jul 29, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (75 total)

• 11:39 PM ET Jul 28, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (128 total)

• 10:57 PM ET Jul 28, 2026
  

  StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (104 total)

• 02:38 AM ET Jul 14, 2026
  

  Medipal Holdings raises FY net income attributable guidance to ¥43.00B vs prior guidance ¥39.00B and FactSet ¥40.16B [4 est, ¥38.40-42.06B] (¥2674.5000, 0)

• 02:35 AM ET Jul 14, 2026
  

  Medipal Holdings raises interim dividend guidance to ¥44/share from ¥34/share (¥2674.5000, 0)

• 02:37 AM ET Jul 08, 2026
  

  Medipal Holdings completes tender offer for Paltac at ¥6,650/share (¥6646.0000, 0)

• 11:05 AM ET May 18, 2026
  

  StreetAccount M&A Summary: Week of 11-May